Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
179 | Biomolecular Detection and Quantification | journal | 1.967 Q1 | 29 | 0 | 15 | 0 | 120 | 14 | 0.00 | 0.00 | 0.00 | |
178 | Drug Discovery Today: Disease Models | journal | 0.315 Q4 | 33 | 0 | 30 | 0 | 46 | 26 | 1.83 | 0.00 | 0.00 | |
177 | Drug Discovery Today: Technologies | journal | 1.340 Q1 | 62 | 0 | 81 | 0 | 532 | 74 | 4.17 | 0.00 | 0.00 | |
176 | European Pharmaceutical Review | trade journal | 0.103 Q4 | 9 | 0 | 27 | 0 | 1 | 24 | 0.00 | 0.00 | 0.00 | |
175 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.107 Q4 | 14 | 0 | 9 | 0 | 1 | 9 | 0.11 | 0.00 | 0.00 | |
174 | Frontiers in Anti-infective Drug Discovery | book series | 0.131 Q4 | 3 | 0 | 15 | 0 | 7 | 8 | 0.29 | 0.00 | 0.00 | |
173 | Human gene therapy methods | journal | 0.780 Q2 | 38 | 0 | 24 | 0 | 87 | 24 | 0.00 | 0.00 | 0.00 | |
172 | Turkish Computational and Theoretical Chemistry | journal | 0.228 Q4 | 8 | 10 | 30 | 327 | 57 | 30 | 2.45 | 32.70 | 24.00 | |
171 | VacciMonitor | journal | 0.162 Q4 | 5 | 19 | 56 | 352 | 23 | 51 | 0.40 | 18.53 | 54.39 | |
170 | Current Pharmacogenomics and Personalized Medicine | journal | 0.110 Q4 | 20 | 12 | 37 | 381 | 9 | 32 | 0.24 | 31.75 | 58.54 | |
169 | Molecular and Cellular Oncology | journal | 0.436 Q3 | 37 | 17 | 312 | 392 | 347 | 220 | 1.05 | 23.06 | 54.55 | |
168 | Pteridines | journal | 0.175 Q4 | 19 | 11 | 56 | 414 | 29 | 56 | 0.44 | 37.64 | 46.67 | |
167 | Cell Stress | journal | 1.434 Q1 | 27 | 12 | 93 | 451 | 494 | 93 | 5.38 | 37.58 | 51.02 | |
166 | Open Medicinal Chemistry Journal | journal | 0.352 Q4 | 23 | 6 | 22 | 464 | 50 | 19 | 2.75 | 77.33 | 46.67 | |
165 | MCB Molecular and Cellular Biomechanics | journal | 0.180 Q4 | 31 | 20 | 88 | 533 | 47 | 82 | 0.54 | 26.65 | 39.29 | |
164 | International Journal of Molecular and Cellular Medicine | journal | 0.447 Q3 | 22 | 13 | 83 | 594 | 195 | 82 | 2.29 | 45.69 | 55.93 | |
163 | Chinese Journal of Cancer Biotherapy | journal | 0.106 Q4 | 5 | 18 | 499 | 608 | 36 | 494 | 0.07 | 33.78 | 32.08 | |
162 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.663 Q3 | 29 | 7 | 24 | 608 | 185 | 7 | 7.64 | 86.86 | 0.00 | |
161 | Journal of Stem Cells | journal | 0.102 Q4 | 21 | 4 | 37 | 651 | 2 | 36 | 0.07 | 162.75 | 66.67 | |
160 | Blood Cells, Molecules, and Diseases | journal | 0.718 Q3 | 98 | 27 | 241 | 828 | 459 | 198 | 1.90 | 30.67 | 44.97 | |
159 | Clinical and Experimental Morphology | journal | 0.123 Q4 | 4 | 32 | 95 | 843 | 30 | 95 | 0.42 | 26.34 | 63.08 | |
158 | Proceedings of the Shevchenko Scientific Society. Medical Sciences | journal | 0.128 Q4 | 4 | 36 | 105 | 861 | 27 | 100 | 0.35 | 23.92 | 50.00 | |
157 | Molecular Imaging | journal | 0.697 Q3 | 66 | 21 | 56 | 902 | 188 | 56 | 2.59 | 42.95 | 40.40 | |
156 | Cellular Therapy and Transplantation | journal | 0.129 Q4 | 8 | 30 | 150 | 916 | 36 | 102 | 0.35 | 30.53 | 58.75 | |
155 | European Journal of Hybrid Imaging | journal | 0.453 Q3 | 14 | 37 | 71 | 976 | 161 | 68 | 2.32 | 26.38 | 30.90 | |
154 | Current Enzyme Inhibition | journal | 0.174 Q4 | 19 | 22 | 69 | 1028 | 44 | 61 | 0.69 | 46.73 | 37.50 | |
153 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.298 Q4 | 39 | 20 | 62 | 1174 | 101 | 60 | 1.00 | 58.70 | 43.18 | |
152 | SLAS Discovery | journal | 1.042 Q2 | 33 | 56 | 318 | 1177 | 961 | 298 | 3.04 | 21.02 | 38.21 | |
151 | Eurobiotech Journal | journal | 0.230 Q4 | 10 | 17 | 71 | 1286 | 143 | 70 | 1.96 | 75.65 | 38.46 | |
150 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q4 | 45 | 29 | 106 | 1316 | 124 | 100 | 1.09 | 45.38 | 27.59 | |
149 | Expert Review of Precision Medicine and Drug Development | journal | 0.317 Q4 | 16 | 18 | 120 | 1413 | 173 | 94 | 1.04 | 78.50 | 26.79 | |
148 | Assay and Drug Development Technologies | journal | 0.358 Q4 | 65 | 34 | 128 | 1424 | 265 | 120 | 1.78 | 41.88 | 39.47 | |
147 | Pharmacogenetics and Genomics | journal | 0.486 Q3 | 152 | 40 | 87 | 1553 | 196 | 84 | 2.61 | 38.83 | 43.43 | |
146 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 31 | 138 | 1572 | 563 | 137 | 4.25 | 50.71 | 28.93 | |
145 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.159 Q4 | 16 | 37 | 119 | 1635 | 67 | 119 | 0.65 | 44.19 | 57.67 | |
144 | Molecular Cytogenetics | journal | 0.443 Q3 | 38 | 52 | 162 | 1641 | 273 | 161 | 1.32 | 31.56 | 57.93 | |
143 | Pharmacogenomics Journal | journal | 0.621 Q3 | 95 | 38 | 215 | 1655 | 656 | 212 | 2.93 | 43.55 | 37.08 | |
142 | Advances in Biological Regulation | journal | 1.276 Q1 | 69 | 30 | 123 | 1710 | 535 | 117 | 4.00 | 57.00 | 42.74 | |
141 | Clinical and Translational Medicine | journal | 1.706 Q1 | 18 | 38 | 59 | 1817 | 279 | 25 | 4.81 | 47.82 | 39.48 | |
140 | OBM Genetics | journal | 0.153 Q4 | 4 | 27 | 84 | 1822 | 23 | 77 | 0.22 | 67.48 | 60.22 | |
139 | Current Cancer Therapy Reviews | journal | 0.147 Q4 | 17 | 37 | 88 | 1901 | 43 | 79 | 0.52 | 51.38 | 45.69 | |
138 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 32 | 42 | 195 | 1983 | 312 | 187 | 1.66 | 47.21 | 45.93 | |
137 | Biomarker Insights | journal | 0.878 Q2 | 40 | 32 | 51 | 2034 | 182 | 44 | 3.51 | 63.56 | 44.16 | |
136 | Nanomedicine Research Journal | journal | 0.255 Q4 | 20 | 40 | 112 | 2035 | 179 | 112 | 1.49 | 50.88 | 49.35 | |
135 | Cold Spring Harbor molecular case studies | journal | 0.854 Q2 | 25 | 71 | 197 | 2059 | 439 | 195 | 1.70 | 29.00 | 48.52 | |
134 | NeuroMolecular Medicine | journal | 1.069 Q2 | 82 | 47 | 147 | 2241 | 700 | 146 | 4.00 | 47.68 | 41.91 | |
133 | Personalized Medicine | journal | 0.358 Q4 | 36 | 50 | 159 | 2255 | 271 | 146 | 1.99 | 45.10 | 50.16 | |
132 | Clinical Proteomics | journal | 0.941 Q2 | 42 | 48 | 111 | 2320 | 458 | 110 | 3.67 | 48.33 | 44.59 | |
131 | Nucleic Acid Therapeutics | journal | 1.490 Q1 | 77 | 46 | 118 | 2358 | 481 | 115 | 3.97 | 51.26 | 37.31 | |
130 | Extremophiles | journal | 0.653 Q3 | 95 | 36 | 185 | 2548 | 577 | 185 | 3.32 | 70.78 | 37.50 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®